Literature DB >> 19295614

Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.

Erin G Harper1, Changsheng Guo, Heather Rizzo, Joseph V Lillis, Stephen E Kurtz, Iliyana Skorcheva, David Purdy, Erin Fitch, Mihail Iordanov, Andrew Blauvelt.   

Abstract

T helper (Th) 17 cells have recently been implicated in psoriasis pathogenesis, but mechanisms of how these cells traffic into inflamed skin are unknown. By immunostaining for interleukin (IL)-17A and IL-22, we show numerous cells present in psoriasis lesions that produce these cytokines. We next found that Th17 cytokines (IL-17A, IL-22, and tumor necrosis factor (TNF)-alpha) markedly increased the expression of CC chemokine ligand (CCL) 20, a CC chemokine receptor (CCR)6 ligand, in human keratinocyte monolayer and raft cultures in a dose- and time-dependent manner. Lastly, we showed in mice that subcutaneous injection with recombinant IL-17A, IL-22, or TNF-alpha led to the upregulation of both CCL20 and CCR6 expression in skin as well as cutaneous T-cell infiltration. Taken together, these data show that Th17 cytokines stimulate CCL20 production in vitro and in vivo, and thus provide a potential explanation of how CCR6-positive Th17 cells maintain their continual presence in psoriasis through a positive chemotactic feedback loop.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19295614      PMCID: PMC2892172          DOI: 10.1038/jid.2009.65

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  38 in total

1.  Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.

Authors:  Ilona Kryczek; Allen T Bruce; Johann E Gudjonsson; Andrew Johnston; Abhishek Aphale; Linhua Vatan; Wojciech Szeliga; Yin Wang; Yan Liu; Theodore H Welling; James T Elder; Weiping Zou
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

2.  The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients.

Authors:  L M Austin; M Ozawa; T Kikuchi; I B Walters; J G Krueger
Journal:  J Invest Dermatol       Date:  1999-11       Impact factor: 8.551

3.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis.

Authors:  Peck Y Ong; Takaaki Ohtake; Corinne Brandt; Ian Strickland; Mark Boguniewicz; Tomas Ganz; Richard L Gallo; Donald Y M Leung
Journal:  N Engl J Med       Date:  2002-10-10       Impact factor: 91.245

4.  Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis.

Authors:  B Homey; M C Dieu-Nosjean; A Wiesenborn; C Massacrier; J J Pin; E Oldham; D Catron; M E Buchanan; A Müller; R deWaal Malefyt; G Deng; R Orozco; T Ruzicka; P Lehmann; S Lebecque; C Caux; A Zlotnik
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

5.  Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array.

Authors:  Xianghong Zhou; James G Krueger; Ming-Chih J Kao; Ed Lee; Fenghe Du; Alan Menter; Wing Hung Wong; Anne M Bowcock
Journal:  Physiol Genomics       Date:  2003-03-18       Impact factor: 3.107

6.  Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells.

Authors:  Michelle A Lowes; Toyoko Kikuchi; Judilyn Fuentes-Duculan; Irma Cardinale; Lisa C Zaba; Asifa S Haider; Edward P Bowman; James G Krueger
Journal:  J Invest Dermatol       Date:  2008-01-17       Impact factor: 8.551

7.  Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial.

Authors:  Alexa B Kimball; Kenneth B Gordon; Richard G Langley; Alan Menter; Elliot K Chartash; Joaquin Valdes
Journal:  Arch Dermatol       Date:  2008-02

8.  The UV (Ribotoxic) stress response of human keratinocytes involves the unexpected uncoupling of the Ras-extracellular signal-regulated kinase signaling cascade from the activated epidermal growth factor receptor.

Authors:  Mihail S Iordanov; Remy J Choi; Olga P Ryabinina; Thanh-Hoai Dinh; Robert K Bright; Bruce E Magun
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2).

Authors:  Kim A Papp; Richard G Langley; Mark Lebwohl; Gerald G Krueger; Philippe Szapary; Newman Yeilding; Cynthia Guzzo; Ming-Chun Hsu; Yuhua Wang; Shu Li; Lisa T Dooley; Kristian Reich
Journal:  Lancet       Date:  2008-05-17       Impact factor: 79.321

10.  Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris.

Authors:  Edmund Lee; William L Trepicchio; Judith L Oestreicher; Debra Pittman; Frank Wang; Francesca Chamian; Madhav Dhodapkar; James G Krueger
Journal:  J Exp Med       Date:  2004-01-05       Impact factor: 14.307

View more
  156 in total

Review 1.  New insights in the immunologic basis of psoriasis.

Authors:  Kristine E Nograles; Batya Davidovici; James G Krueger
Journal:  Semin Cutan Med Surg       Date:  2010-03

2.  Pituitary adenylate cyclase-activating peptide and vasoactive intestinal polypeptide bias Langerhans cell Ag presentation toward Th17 cells.

Authors:  Wanhong Ding; Michela Manni; Lori L Stohl; Xi K Zhou; John A Wagner; Richard D Granstein
Journal:  Eur J Immunol       Date:  2012-04       Impact factor: 5.532

3.  IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.

Authors:  Andrew L Croxford; Susanne Karbach; Florian C Kurschus; Simone Wörtge; Alexei Nikolaev; Nir Yogev; Sabrina Klebow; Rebecca Schüler; Sonja Reissig; Carolin Piotrowski; Elke Brylla; Ingo Bechmann; Jürgen Scheller; Stefan Rose-John; F Thomas Wunderlich; Thomas Münzel; Esther von Stebut; Ari Waisman
Journal:  J Invest Dermatol       Date:  2013-09-25       Impact factor: 8.551

4.  Interleukin 23 in the skin: role in psoriasis pathogenesis and selective interleukin 23 blockade as treatment.

Authors:  Tom C Chan; Jason E Hawkes; James G Krueger
Journal:  Ther Adv Chronic Dis       Date:  2018-03-19       Impact factor: 5.091

5.  Phytosphingosine derivatives ameliorate skin inflammation by inhibiting NF-κB and JAK/STAT signaling in keratinocytes and mice.

Authors:  Byung-Hak Kim; Ji Min Lee; Yong-Gyu Jung; Sanghee Kim; Tae-Yoon Kim
Journal:  J Invest Dermatol       Date:  2013-10-31       Impact factor: 8.551

6.  Psoriatic inflammation facilitates the onset of arthritis in a mouse model.

Authors:  Mayuko Yamamoto; Kimiko Nakajima; Mikiro Takaishi; Shun Kitaba; Yasuhiro Magata; Sayo Kataoka; Shigetoshi Sano
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

7.  IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis.

Authors:  Iannis E Adamopoulos; Erika Suzuki; Cheng-Chi Chao; Dan Gorman; Sarvesh Adda; Emanual Maverakis; Konstantinos Zarbalis; Richard Geissler; Agelio Asio; Wendy M Blumenschein; Terrill Mcclanahan; Rene De Waal Malefyt; M Eric Gershwin; Edward P Bowman
Journal:  Ann Rheum Dis       Date:  2014-02-23       Impact factor: 19.103

8.  Regulation of the psoriatic chemokine CCL20 by E3 ligases Trim32 and Piasy in keratinocytes.

Authors:  Yuangang Liu; James P Lagowski; Shangpu Gao; James H Raymond; Clifton R White; Molly F Kulesz-Martin
Journal:  J Invest Dermatol       Date:  2010-01-07       Impact factor: 8.551

9.  IL-17 drives psoriatic inflammation via distinct, target cell-specific mechanisms.

Authors:  Hye-Lin Ha; Hongshan Wang; Prapaporn Pisitkun; Jin-Chul Kim; Ilaria Tassi; Wanhu Tang; Maria I Morasso; Mark C Udey; Ulrich Siebenlist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

Review 10.  Immunology of psoriasis.

Authors:  Michelle A Lowes; Mayte Suárez-Fariñas; James G Krueger
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.